Latest On Corbus Pharmaceuticals Holdings, Inc (CRBP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-11-08 10:30 EST | News | Corbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 | N/A |  |
| 2022-08-09 22:16 EST | News | Corbus Pharmaceuticals GAAP EPS of -$0.11 | N/A | |
| 2022-05-11 02:18 EST | News | Corbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01 | N/A | |
| 2022-03-08 11:50 EST | News | Corbus Pharmaceuticals GAAP EPS of -$0.37 beats by $0.03, revenue of $0.88M beats by $0.04M | N/A | |
| 2021-11-12 19:24 EST | News | Corbus Pharmaceuticals EPS beats by $0.10, misses on revenue | N/A | |
| 2021-07-21 03:17 EST | News | Corbus Pharma gains 9% on licensing deal for monoclonal antibodies in cancer and fibrotic diseases | N/A | |
| 2021-07-21 03:15 EST | News | Corbus Pharmaceuticals (CRBP) Investor Presentation - Slideshow | N/A | |
| 2021-07-21 03:01 EST | News | STSA, AXLA, CVAC and CRBP among after-hours movers | N/A | |
| 2021-07-21 02:55 EST | News | Corbus Pharma hurt by setback in late-stage trial for rare autoimmune disease | N/A | |
| 2021-04-20 22:08 EST | News | Corbus completes enrollment in mid-stage autoimmune disease trial | N/A | |
| 2021-04-15 18:01 EST | News | Corbus: Assessing If Lenabasum Can Finally Break Through | N/A | |
| 2021-03-30 23:42 EST | News | Corbus gives update on late-stage lenabasum trial progress | N/A | |
| 2021-03-18 04:27 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-17 21:09 EST | News | Corbus Pharmaceuticals Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-17 12:26 EST | Analyst Rating | The Analyst Target Price has increased from $2.02 to $2.23. | Buy | |
| 2021-03-16 22:27 EST | News | Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue | N/A | |
| 2021-03-16 22:27 EST | News | Corbus hints at potential pipeline expansion deals, shares rise | N/A | |
| 2021-03-16 22:26 EST | News | Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-16 20:33 EST | Earnings Estimate | An EPS average of -$0.86 is estimated for the 2022 year. | Sell | |
| 2021-03-16 20:33 EST | Earnings Estimate | An EPS average of -$0.13 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-16 20:33 EST | Analyst Rating | The Analyst Target Price has increased from $1.88 to $2.02. | Neutral | |
| 2021-03-05 17:49 EST | News | Seeking Alpha Catalyst Watch | N/A | |
| 2021-02-06 16:40 EST | News | Marijuana as medicine: the other cannabinoid pharma players | N/A | |
| 2021-02-03 00:04 EST | News | INO, VXRT, BTU and TTM among premarket gainers | N/A | |
| 2021-01-29 16:16 EST | News | Corbus Pharmaceuticals: Down But Not Out | N/A | |
| 2021-01-11 11:26 EST | Analyst Rating | The Analyst Target Price has decreased from $6.9 to $1.88. | Neutral | |
| 2020-12-13 03:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 03:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 16:26 EST | News | Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-11 03:31 EST | Earnings Estimate | An EPS average of -$0.26 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-10 10:45 EST | News | Corbus's lenabasum shows benefit in autoimmune disorder | N/A | |
| 2020-11-10 10:45 EST | News | Lenabasum Exposure Wipes Shareholder Upside For Corbus Pharmaceuticals | N/A | |
| 2020-11-10 10:45 EST | News | Corbus Pharmaceutical (CRBP) Phase 3 data lenabasum in systemic sclerosis - Slideshow | N/A | |
| 2020-11-10 10:43 EST | News | Corbus Pharmaceuticals down 4% after Q2 miss; top-line down 52% | N/A | |
| 2020-11-10 10:43 EST | News | Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) CEO Yuval Cohen On Q3 2020 Results - Quick Version Earnings Call Transcript | N/A | |
| 2020-11-07 15:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-23 23:06 EST | News | Abnormality in control group flagged as possible reason for failed study of Corbus Pharma's lenabasum | N/A | |
| 2020-10-13 12:28 EST | Analyst Rating | The Analyst Target Price has decreased from $7.5 to $6.9. | Neutral | |
| 2020-10-08 20:40 EST | News | Corbus Pharma to ax 54% of workforce in cost-cutting move | N/A | |
| 2020-10-08 16:29 EST | Analyst Rating | The Analyst Target Price has decreased from $7.74 to $7.5. | Neutral | |
| 2020-10-07 16:39 EST | Analyst Rating | The Analyst Target Price has decreased from $8.3 to $7.74. | Neutral | |
| 2020-10-07 15:04 EST | News | Roth Capital cuts target price for Corbus Pharmaceuticals | N/A | |
| 2020-10-06 08:11 EST | News | Corbus Pharma's lenabasum flunks mid-stage cystic fibrosis study; shares down 30% | N/A | |
| 2020-09-26 12:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 08:25 EST | Analyst Rating | The Analyst Target Price has decreased from $13.75 to $8.3. | Neutral | |
| 2020-09-09 12:25 EST | Analyst Rating | The Analyst Target Price has decreased from $25.14 to $13.75. | Neutral | |
| 2020-09-08 10:14 EST | News | Corbus Pharma's lenabasum flunks late-stage systemic sclerosis study, shares down 77% | N/A | |
| 2020-09-05 00:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-21 20:33 EST | News | Corbus Pharmaceuticals: Ultra High Implied Volatility Brings Opportunity | N/A | |
About Corbus Pharmaceuticals Holdings, Inc (CRBP):
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase III clinical trials for the treatment of systemic sclerosis and dermatomyositis, and in Phase IIb clinical trials to treat systemic lupus erythematosus and cystic fibrosis. The company is also developing CRB-4001, a peripherally-restricted CB1 inverse agonist, for nonalcoholic steatohepatitis and other fibrotic diseases. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.
General
- Name Corbus Pharmaceuticals Holdings, Inc
- Symbol CRBP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 76
- Fiscal Year EndDecember
- IPO Date2014-11-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.corbuspharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 44.06
- Price/Book (Most Recent Quarter) 6.13
- Enterprise Value Revenue 55.56
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.51
- Next Year EPS Estimate -$0.47
- Next Quarter EPS Estimate -$0.15
- Operating Margin -3119%
- Return on Assets -101%
- Return on Equity -433%
- Revenue 3.94 million
- Earnings Per Share -$0.93
- Revenue Per Share $0.05
- Gross Profit -94329983
- Quarterly Earnings Growth -74.4%
View More
Highlights
- Market Capitalization 269.86 million
- EBITDA -56710588
- PE Ratio -16.14
- Analyst Target Price $2.23
- Book Value Per Share $0.46
View More
Share Statistics
- Shares Outstanding 124.94 million
- Shares Float 115.36 million
- % Held by Insiders 173%
- % Held by Institutions 75.49%
- Shares Short 13.58 million
- Shares Short Prior Month 22.14 million
- Short Ratio 0.52
- Short % of Float 20%
- Short % of Shares Outstanding 16%
View More
Technicals
- Beta 2
- 52 Week High $9.78
- 52 Week Low $0.91
- 50 Day Moving Average 2.48
- 200 Day Moving Average 1.98
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Corbus Pharmaceuticals Holdings, Inc (CRBP) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Corbus Pharmaceuticals Holdings, Inc (CRBP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-15 | $658204 | -$0.10 | -$0.25 | 60% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.43 | -$0.41 | -5.91% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.52 | -$0.38 | -38.67% |
| 2020-03-31 | 2020-05-11 | $1.76 million | -$0.43 | -$0.42 | -1.58% |
| 2019-12-31 | 2020-03-12 | $2.57 million | -$0.41 | -$0.36 | -14.53% |
| 2019-09-30 | 2019-11-07 | $2.59 million | -$0.32 | -$0.36 | 11.92% |
| 2019-06-30 | 2019-08-08 | $29.09 million | $0.03 | -$0.36 | 108.43% |
| 2019-03-31 | 2019-05-09 | $1.89 million | -$0.43 | -$0.15 | -189.95% |
| 2018-12-31 | 2019-03-12 | $1.93 million | -$0.31 | -$0.27 | -16.24% |
| 2018-09-30 | 2018-11-08 | $1.09 million | -$0.26 | -$0.22 | -17.28% |
| 2018-06-30 | 2018-08-08 | $853646 | -$0.21 | -$0.22 | 2.33% |
| 2018-03-31 | 2018-05-10 | $950442 | -$0.21 | -$0.15 | -44.83% |
| 2017-12-31 | 2018-03-12 | $1.64 million | -$0.21 | -$0.15 | -36.36% |
| 2017-09-30 | 2017-11-08 | $796000 | -$0.14 | -$0.16 | 12.5% |
| 2017-06-30 | 2017-08-09 | $350000 | -$0.15 | -$0.19 | 19.66% |
| 2017-03-31 | 2017-05-09 | $1.29 million | -$0.16 | -$0.16 | 0% |
| 2016-12-31 | 2017-03-08 | $375000 | -$0.18 | -$0.14 | -31.68% |
| 2016-09-30 | 2016-11-10 | $743000 | -$0.12 | -$0.11 | -9.09% |
| 2016-06-30 | 2016-08-12 | $396000 | -$0.11 | -$0.08 | -46.67% |
| 2016-03-31 | 2016-05-13 | $397000 | -$0.08 | -$0.08 | 0% |
| 2015-12-31 | 2016-03-28 | $364000 | -$0.06 | -$0.07 | 17.24% |
| 2015-09-30 | 2015-11-11 | $170000 | -$0.06 | -$0.08 | 25% |
| 2015-06-30 | 2015-08-13 | $114000 | -$0.10 | ||
| 2015-03-31 | 2015-05-13 | $N/A | -$0.06 | ||
| 2014-12-31 | 2015-02-10 | $N/A | -$0.05 |
Corbus Pharmaceuticals Holdings, Inc (CRBP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Corbus Pharmaceuticals Holdings, Inc (CRBP) Chart:
Corbus Pharmaceuticals Holdings, Inc (CRBP) News:
Below you will find a list of latest news for Corbus Pharmaceuticals Holdings, Inc (CRBP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Corbus Pharmaceuticals Holdings, Inc (CRBP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2.5 | 8.05 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 5 | 2.95 | CALL | 0 | 33 | 193.18 | TRUE | 0 | 0 |
| 2026-06-18 | 7.5 | 0.7 | CALL | 4 | 369 | 97 | TRUE | -0.4 | -0.36 |
| 2026-06-18 | 10 | 0.25 | CALL | 49 | 1516 | 135.87 | FALSE | -0.1 | -0.29 |
| 2026-06-18 | 12.5 | 0.07 | CALL | 93 | 3158 | 158.77 | FALSE | -0.04 | -0.36 |
| 2026-06-18 | 15 | 0.08 | CALL | 40 | 2239 | 199.54 | FALSE | 0.05 | 1.67 |
| 2026-06-18 | 17.5 | 0 | CALL | 0 | 1 | 394.54 | FALSE | 0 | 0 |
| 2026-06-18 | 20 | 0.1 | CALL | 0 | 291 | 395.55 | FALSE | 0 | 0 |
| 2026-06-18 | 22.5 | 0.25 | CALL | 0 | 13 | 477.03 | FALSE | 0 | 0 |
| 2026-06-18 | 25 | 0 | CALL | 0 | 4 | 633.28 | FALSE | 0 | 0 |
| 2026-06-18 | 30 | 0.05 | CALL | 0 | 321 | 546.01 | FALSE | 0 | 0 |
| 2026-06-18 | 2.5 | 0 | PUT | 0 | 40 | 271.03 | FALSE | 0 | 0 |
| 2026-06-18 | 5 | 0.02 | PUT | 0 | 10 | 134.06 | FALSE | 0 | 0 |
| 2026-06-18 | 7.5 | 0.5 | PUT | 10 | 1009 | 98.86 | FALSE | -0.15 | -0.23 |
| 2026-06-18 | 10 | 2.5 | PUT | 0 | 105 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 12.5 | 2.95 | PUT | 0 | 8 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 17.5 | 10.04 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 20 | 0 | PUT | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 22.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 25 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 30 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 2.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 5 | 0 | CALL | 0 | 0 | 138.68 | TRUE | 0 | 0 |
| 2026-07-17 | 7.5 | 1.4 | CALL | 4 | 9 | 100.46 | TRUE | -0.2 | -0.13 |
| 2026-07-17 | 10 | 0.6 | CALL | 12 | 6072 | 101.26 | FALSE | -0.05 | -0.08 |
| 2026-07-17 | 12.5 | 0.2 | CALL | 0 | 0 | 132.67 | FALSE | 0 | 0 |
| 2026-07-17 | 15 | 1 | CALL | 0 | 500 | 225.06 | FALSE | 0 | 0 |
| 2026-07-17 | 17.5 | 0.96 | CALL | 0 | 5 | 339.73 | FALSE | 0 | 0 |
| 2026-07-17 | 20 | 0 | CALL | 0 | 0 | 410.9 | FALSE | 0 | 0 |
| 2026-07-17 | 22.5 | 0 | CALL | 0 | 0 | 360.01 | FALSE | 0 | 0 |
| 2026-07-17 | 2.5 | 0 | PUT | 0 | 0 | 165.15 | FALSE | 0 | 0 |
| 2026-07-17 | 5 | 0.08 | PUT | 0 | 46 | 119.66 | FALSE | 0 | 0 |
| 2026-07-17 | 7.5 | 1.1 | PUT | 0 | 215 | 91.72 | FALSE | 0 | 0 |
| 2026-07-17 | 10 | 1.7 | PUT | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 12.5 | 0 | PUT | 0 | 0 | 118.73 | TRUE | 0 | 0 |
| 2026-07-17 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 17.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 20 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 22.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-09-18 | 2.5 | 5.47 | CALL | 0 | 2 | 175.64 | TRUE | 0 | 0 |
| 2026-09-18 | 5 | 3.7 | CALL | 0 | 704 | 155.11 | TRUE | 0 | 0 |
| 2026-09-18 | 7.5 | 2.85 | CALL | 0 | 94 | 125.18 | TRUE | 0 | 0 |
| 2026-09-18 | 10 | 1.5 | CALL | 14 | 103 | 118.81 | FALSE | 1.5 | 0 |
| 2026-09-18 | 12.5 | 1 | CALL | 2 | 2283 | 124.97 | FALSE | 0.15 | 0.18 |
| 2026-09-18 | 15 | 0.87 | CALL | 0 | 132 | 121.69 | FALSE | 0 | 0 |
| 2026-09-18 | 17.5 | 2.16 | CALL | 0 | 21 | 127.23 | FALSE | 0 | 0 |
| 2026-09-18 | 20 | 0.74 | CALL | 1 | 768 | 141.62 | FALSE | 0.74 | 0 |
| 2026-09-18 | 22.5 | 0.9 | CALL | 1 | 26 | 145.48 | FALSE | 0.9 | 0 |
| 2026-09-18 | 2.5 | 0.1 | PUT | 0 | 40 | 141.73 | FALSE | 0 | 0 |
| 2026-09-18 | 5 | 0.6 | PUT | 0 | 4 | 254.48 | FALSE | 0 | 0 |
| 2026-09-18 | 7.5 | 1.76 | PUT | 0 | 60 | 113.99 | FALSE | 0 | 0 |
| 2026-09-18 | 10 | 3.6 | PUT | 0 | 30 | 116.91 | TRUE | 0 | 0 |
| 2026-09-18 | 12.5 | 4.4 | PUT | 0 | 7 | 119.07 | TRUE | 0 | 0 |
| 2026-09-18 | 15 | 0 | PUT | 0 | 8 | 122.95 | TRUE | 0 | 0 |
| 2026-09-18 | 17.5 | 0 | PUT | 0 | 0 | 122.86 | TRUE | 0 | 0 |
| 2026-09-18 | 20 | 0 | PUT | 0 | 0 | 125.97 | TRUE | 0 | 0 |
| 2026-09-18 | 22.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 2.5 | 5.9 | CALL | 0 | 19 | 126.32 | TRUE | 0 | 0 |
| 2026-12-18 | 5 | 3.9 | CALL | 0 | 1 | 179.31 | TRUE | 0 | 0 |
| 2026-12-18 | 7.5 | 3.2 | CALL | 0 | 221 | 122.7 | TRUE | 0 | 0 |
| 2026-12-18 | 10 | 2 | CALL | 0 | 5 | 152.51 | FALSE | 0 | 0 |
| 2026-12-18 | 12.5 | 1.85 | CALL | 0 | 199 | 107.22 | FALSE | 0 | 0 |
| 2026-12-18 | 15 | 1.5 | CALL | 19 | 3904 | 133.96 | FALSE | 1.5 | 0 |
| 2026-12-18 | 17.5 | 1.15 | CALL | 1 | 862 | 137.27 | FALSE | 1.15 | 0 |
| 2026-12-18 | 20 | 1.49 | CALL | 2 | 7080 | 140.32 | FALSE | 1.49 | 0 |
| 2026-12-18 | 22.5 | 0.85 | CALL | 11 | 3579 | 130.11 | FALSE | -0.15 | -0.15 |
| 2026-12-18 | 2.5 | 0.06 | PUT | 0 | 1 | 105.4 | FALSE | 0 | 0 |
| 2026-12-18 | 5 | 0.89 | PUT | 0 | 6 | 89.4 | FALSE | 0 | 0 |
| 2026-12-18 | 7.5 | 2 | PUT | 0 | 3 | 127.06 | FALSE | 0 | 0 |
| 2026-12-18 | 10 | 4 | PUT | 0 | 4 | 126.21 | TRUE | 0 | 0 |
| 2026-12-18 | 12.5 | 4.52 | PUT | 0 | 18 | 124.96 | TRUE | 0 | 0 |
| 2026-12-18 | 15 | 6 | PUT | 0 | 4 | 124.12 | TRUE | 0 | 0 |
| 2026-12-18 | 17.5 | 0 | PUT | 0 | 0 | 125.71 | TRUE | 0 | 0 |
| 2026-12-18 | 20 | 12.8 | PUT | 0 | 3 | 124 | TRUE | 0 | 0 |
| 2026-12-18 | 22.5 | 0 | PUT | 0 | 0 | 124.77 | TRUE | 0 | 0 |
Latest CRBP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 6:21 PM EST | 267 | $0.2624 |
| Jun 13, 2022 6:21 PM EST | 300 | $0.2624 |
| Jun 13, 2022 6:23 PM EST | 50 | $0.2624 |
| Jun 13, 2022 6:24 PM EST | 50 | $0.2624 |
| Jun 13, 2022 6:24 PM EST | 50 | $0.2624 |
Corbus Pharmaceuticals Holdings, Inc (CRBP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm |
| 2019-06-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1595097/000000000019009641/0000000000-19-009641-index.htm |
| 2019-07-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1595097/000000000019011115/0000000000-19-011115-index.htm |
| 2020-04-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1595097/000000000020003171/0000000000-20-003171-index.htm |
| 2020-10-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000009375120000967/0000093751-20-000967-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000021545719003233/0000215457-19-003233-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000083423720005448/0000834237-20-005448-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000090571819000212/0000905718-19-000212-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000110465920021777/0001104659-20-021777-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000114420419007532/0001144204-19-007532-index.htm |
| 2018-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm |
| 2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118033766/0001209191-18-033766-index.htm |
| 2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118033770/0001209191-18-033770-index.htm |
| 2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118033772/0001209191-18-033772-index.htm |
| 2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118033781/0001209191-18-033781-index.htm |
| 2018-06-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118035974/0001209191-18-035974-index.htm |
| 2018-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118035975/0001209191-18-035975-index.htm |
| 2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119004573/0001209191-19-004573-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119004574/0001209191-19-004574-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119004577/0001209191-19-004577-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119004579/0001209191-19-004579-index.htm |
| 2019-03-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119015953/0001209191-19-015953-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119015958/0001209191-19-015958-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm |
| 2019-04-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119023973/0001209191-19-023973-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119023975/0001209191-19-023975-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039459/0001209191-19-039459-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039463/0001209191-19-039463-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039465/0001209191-19-039465-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039467/0001209191-19-039467-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039468/0001209191-19-039468-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119039469/0001209191-19-039469-index.htm |
| 2019-08-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045052/0001209191-19-045052-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045053/0001209191-19-045053-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120017383/0001209191-20-017383-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120017393/0001209191-20-017393-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120017400/0001209191-20-017400-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120017408/0001209191-20-017408-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120017413/0001209191-20-017413-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031658/0001209191-20-031658-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031659/0001209191-20-031659-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031660/0001209191-20-031660-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031661/0001209191-20-031661-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031662/0001209191-20-031662-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm |
| 2019-12-02 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000121390019025087/0001213900-19-025087-index.htm |
| 2020-03-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000121390020006823/0001213900-20-006823-index.htm |
| 2020-04-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000121390020010018/0001213900-20-010018-index.htm |
| 2020-08-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000121390020020809/0001213900-20-020809-index.htm |
| 2020-11-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000121390020035462/0001213900-20-035462-index.htm |
| 2018-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218007765/0001493152-18-007765-index.htm |
| 2018-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218008253/0001493152-18-008253-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218008575/0001493152-18-008575-index.htm |
| 2018-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218010415/0001493152-18-010415-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218011138/0001493152-18-011138-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315218011140/0001493152-18-011140-index.htm |
| 2018-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218013520/0001493152-18-013520-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315218015410/0001493152-18-015410-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315218015417/0001493152-18-015417-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219000082/0001493152-19-000082-index.htm |
| 2019-01-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219000901/0001493152-19-000901-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219000956/0001493152-19-000956-index.htm |
| 2019-01-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219001023/0001493152-19-001023-index.htm |
| 2019-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219001156/0001493152-19-001156-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219003129/0001493152-19-003129-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/0001493152-19-003143-index.htm |
| 2019-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1595097/000149315219003206/0001493152-19-003206-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219004518/0001493152-19-004518-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219005015/0001493152-19-005015-index.htm |
| 2019-04-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1595097/000149315219005114/0001493152-19-005114-index.htm |
| 2019-04-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1595097/000149315219005115/0001493152-19-005115-index.htm |
| 2019-04-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219005599/0001493152-19-005599-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219006607/0001493152-19-006607-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219006611/0001493152-19-006611-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219008125/0001493152-19-008125-index.htm |
| 2019-06-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1595097/000149315219009707/0001493152-19-009707-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219011831/0001493152-19-011831-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219011835/0001493152-19-011835-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219016583/0001493152-19-016583-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315219016601/0001493152-19-016601-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315219018312/0001493152-19-018312-index.htm |
| 2020-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220001701/0001493152-20-001701-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220001766/0001493152-20-001766-index.htm |
| 2020-02-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220001838/0001493152-20-001838-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220003644/0001493152-20-003644-index.htm |
| 2020-03-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000149315220003662/0001493152-20-003662-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000149315220003663/0001493152-20-003663-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220003772/0001493152-20-003772-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/0001493152-20-004077-index.htm |
| 2020-03-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1595097/000149315220004157/0001493152-20-004157-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220005602/0001493152-20-005602-index.htm |
| 2020-04-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1595097/000149315220005953/0001493152-20-005953-index.htm |
| 2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220005955/0001493152-20-005955-index.htm |
| 2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1595097/000149315220006110/0001493152-20-006110-index.htm |
| 2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1595097/000149315220006111/0001493152-20-006111-index.htm |
| 2020-04-21 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220006836/0001493152-20-006836-index.htm |
| 2020-04-24 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1595097/000149315220007094/0001493152-20-007094-index.htm |
| 2020-04-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1595097/000149315220007096/0001493152-20-007096-index.htm |
| 2020-04-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1595097/000149315220007445/0001493152-20-007445-index.htm |
| 2020-05-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220007596/0001493152-20-007596-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220008150/0001493152-20-008150-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220008248/0001493152-20-008248-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220009623/0001493152-20-009623-index.htm |
| 2020-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220012800/0001493152-20-012800-index.htm |
| 2020-07-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000149315220012801/0001493152-20-012801-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595097/000149315220012802/0001493152-20-012802-index.htm |
| 2020-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220014133/0001493152-20-014133-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220014810/0001493152-20-014810-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220014895/0001493152-20-014895-index.htm |
| 2020-08-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220014902/0001493152-20-014902-index.htm |
| 2020-08-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220014904/0001493152-20-014904-index.htm |
| 2020-08-31 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595097/000149315220017022/0001493152-20-017022-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220017365/0001493152-20-017365-index.htm |
| 2020-09-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220017794/0001493152-20-017794-index.htm |
| 2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220018325/0001493152-20-018325-index.htm |
| 2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220018978/0001493152-20-018978-index.htm |
| 2020-10-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595097/000149315220019126/0001493152-20-019126-index.htm |
| 2018-10-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000161577418011405/0001615774-18-011405-index.htm |
| 2019-02-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000161577419002673/0001615774-19-002673-index.htm |
| 2019-04-29 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000161577419006505/0001615774-19-006505-index.htm |
| 2019-06-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595097/000161577419009075/0001615774-19-009075-index.htm |
| 2020-05-01 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1595097/999999999520001005/9999999995-20-001005-index.htm |
| 2018-12-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1595097/999999999718009293/9999999997-18-009293-index.htm |
| 2019-03-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1595097/999999999719000685/9999999997-19-000685-index.htm |
Corbus Pharmaceuticals Holdings, Inc (CRBP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corbus Pharmaceuticals Holdings, Inc (CRBP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 173%Institutional Ownership: 7549%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-03-15 | John Kenneth Jenkins | Director | Buy | 1,000.00 | 6.98 | 6,977.90 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm |
| 2019-11-11 | Craig Stuart Millian | Chief Commercial Officer | Buy | 1,000.00 | 4.38 | 4,380.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm |
| 2020-03-17 | Craig Stuart Millian | Chief Commercial Officer | Buy | 2,000.00 | 4.25 | 8,500.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm |
| 2018-05-15 | Barbara White | Chief Medical Officer | Buy | 2,586.00 | 5.87 | 15,174.39 | 179,521.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm |
| 2019-03-14 | Barbara White | Chief Medical Officer | Buy | 4,638.00 | 6.47 | 29,993.95 | 184,159.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm |
| 2019-05-17 | Barbara White | Chief Medical Officer | Buy | 1,389.00 | 7.20 | 10,000.80 | 185,548.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm |
| 2019-08-12 | Barbara White | Chief Medical Officer | Buy | 1,639.00 | 6.10 | 9,997.90 | 187,187.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm |
| 2019-11-12 | Barbara White | Chief Medical Officer | Buy | 3,424.00 | 4.38 | 14,991.64 | 190,611.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm |
| 2020-03-17 | Barbara White | Chief Medical Officer | Buy | 15,606.00 | 3.63 | 56,649.78 | 206,217.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm |
| 2018-11-14 | Mark Tepper | President and CSO | Buy | 10,000.00 | 1.00 | 10,000.00 | 2,110,400.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm |
| 2019-08-12 | Robert Paul Discordia | Chief Operating Officer | Buy | 15,000.00 | 5.86 | 87,894.00 | 30,150.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm |
| 2019-11-11 | Robert Paul Discordia | Chief Operating Officer | Buy | 2,500.00 | 4.62 | 11,558.50 | 32,650.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm |
| 2019-03-14 | Sean F. Moran | Chief Financial Officer | Buy | 1,500.00 | 6.67 | 10,005.00 | 349,510.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm |
| 2019-05-14 | Sean F. Moran | Chief Financial Officer | Buy | 100.00 | 7.12 | 712.00 | 349,610.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm |
| 2020-03-17 | Robert Paul Discordia | Chief Operating Officer | Buy | 2,840.00 | 3.54 | 10,053.60 | 35,490.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm |
| 2019-03-14 | Craig Stuart Millian | Chief Commercial Officer | Buy | 5,000.00 | 6.85 | 34,258.50 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm |
| 2019-05-14 | Craig Stuart Millian | Chief Commercial Officer | Buy | 1,000.00 | 7.23 | 7,226.60 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm |
| 2019-03-14 | Yuval Cohen | Chief Executive Officer | Buy | 1,530.00 | 6.49 | 9,929.70 | 63,190.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm |
| 2019-05-13 | Yuval Cohen | Chief Executive Officer | Buy | 995.00 | 6.99 | 6,954.85 | 64,185.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm |
| 2019-08-12 | Yuval Cohen | Chief Executive Officer | Buy | 1,175.00 | 6.06 | 7,115.80 | 65,360.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm |
| 2019-11-12 | Yuval Cohen | Chief Executive Officer | Buy | 1,430.00 | 4.26 | 6,091.80 | 66,790.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm |
| 2019-03-15 | David P Hochman | Director | Buy | 2,000.00 | 6.98 | 13,957.60 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm |
| 2020-03-17 | Yuval Cohen | Chief Executive Officer | Buy | 4,300.00 | 3.49 | 15,007.00 | 71,090.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm |
| 2019-08-12 | Craig Stuart Millian | Chief Commercial Officer | Buy | 1,500.00 | 6.00 | 9,000.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm |
| 2019-08-15 | Craig Stuart Millian | Chief Commercial Officer | Buy | 1,500.00 | 5.48 | 8,212.95 | 9,000.00 | https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm |